About ORx Pharmaceutical
ORx Pharmaceutical: Who We Are
ORx Pharmaceutical Corporation ('or-ex') is an advanced drug delivery specialty pharmaceutical company with a focus on the design, development and clinical testing of new and advanced dosage forms of promising drug compounds with the aim of improving their clinical performance and patient care.
ORx develops and have developed a complementary suite of patented advanced drug delivery and bio-enabling technologies geared towards optimizing the bio-absorption and improving delivery to target sites of new and existing pharmaceutical drugs with poor or sub-optimal bioavailability and efficacy.
The Vision of ORx Pharmaceutical
ORx is employing advanced bio-enabling drug delivery technologies to develop new and improved pharmaceutical products. Our mission is to develop therapies that will improve the quality of life for patients with acute and chronic diseases and conditions. Our vision for product development is to combine known drugs with promising efficacy with ORx’s technology to create value-added drug products with lower development risks and quicker access to the market.
ORx's strategy involves:
1. development proprietary pharmaceutical products using an approach that minimizes risk and maximizes speed to the market.
2. enhancement of bio-performance and optimized delivery of orally ingestible pharmaceutical compounds.
3. enabling the oral absorption of parenteral therapeutic products.
4. expansion of technology platforms through co-developments and internal work.
Commitment to Patient Care
Our goal is to develop improved drug products that have the potential to be a more convenient, patient-friendly medicine that provides an alternative to current therapies for treatment of various acute and chronic conditions. The distinct advantage to the patient and the physician is convenience, control, and improved effectiveness. The physician has added assurance that the patient is receiving the proper dose of medicine with fewer concerns about missed prescriptions or non-compliance.
ORx Pharmaceutical History
Orx was founded in 2002 by Dr. Alexander MacGregor, a pharmaceutical technology expert, professor of bio-pharmaceutics and the founder of the North America’s preeminent postgraduate pharmaceutical Institute- the Toronto Institute of Pharmaceutical Technology (TIPT)
Orx’s foundation is based on the utilization of the most advanced technologies in pharmaceutical drug delivery and drug targeting backed by several years of translational research.
Today Orx is managed by a team of science experts and proven business managers responsible for improving shareholder value while deploying advanced patented technologies to creating new product opportunities.
The ORx Pharmaceutical Business Focus
ORx works primarily to improve therapeutic performance of established and promising drugs. ORx introduces product improvements to current drugs enabling product life extension options, and branding opportunities. The Company's products have the added benefit of patent protection from issued and pending ORx platform and product specific patents. In most cases, unlike a full new drug application (NDA) ORx product approvals require only limited clinical assessment resulting in inexpensive and expedient new product development and registration; for example via the 505(b)(2) regulatory option in the US.